New article: Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. https://t.co/STGBkjAX9a #MMSM #MultipleMyeloma #hematology
925 followers
369 followers
Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma https://t.co/06hejIAXBX
1,196 followers
RT @alex_akanell: R-BEAM with Rituximab in mobilisation and days +1 and +8, was safe and confered high 5-yr OS 73% negating the COO effect-…
409 followers
R-BEAM with Rituximab in mobilisation and days +1 and +8, was safe and confered high 5-yr OS 73% negating the COO effect- (Similar OS and DFS for patients with transformed DLBCL or with GCB or a non-GCB DLBCL). All pts were Rituximab pre-treated. https://